AI assistant
PFIZER INC — Director's Dealing 2021
Mar 1, 2021
29831_dirs_2021-03-01_8270c7d7-8911-4d70-b4b9-3c11fca90c69.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2021-02-25
Reporting Person: MACKENZIE ALEXANDER R (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-25 | Common Stock | A | 26732.0000 | $0.0000 | Acquired | 137727.0000 | Direct |
| 2021-02-25 | Common Stock | F | 14227.0000 | $33.8200 | Disposed | 123500.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-25 | Stock Appreciation Rights | $33.8200 | A | 84279.0000 | Acquired | 2026-02-25 | Common Stock (84279.0000) | Direct |
| 2021-02-25 | Stock Appreciation Rights | $33.8200 | A | 72820.0000 | Acquired | 2028-02-25 | Common Stock (72820.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 10106.0000 | Indirect |
Footnotes
F1: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon).
F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon).
F3: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F4: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.